Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 6;18(2):sfae397.
doi: 10.1093/ckj/sfae397. eCollection 2025 Feb.

Multiethnic prevalence of the APOL1 G1 and G2 variants among the Israeli dialysis population

Affiliations

Multiethnic prevalence of the APOL1 G1 and G2 variants among the Israeli dialysis population

Dror Ben-Ruby et al. Clin Kidney J. .

Abstract

Background and hypothesis: The two apolipoprotein L1 (APOL1) variants, G1 and G2, are common in populations of sub-Saharan African ancestry. Individuals with two of these alleles (G1 or G2) have an increased risk for a spectrum of non-diabetic chronic kidney diseases. However, these variants are typically not observed outside of populations that self-identify as current continental Africans or having clear recent African ancestry such as, most notably, African Americans, and other large population groups in the Americas and several European countries. We hypothesized that the diverse ethnic groups within the Israeli population may exhibit varying levels of recent African ancestry. Therefore, it is plausible that APOL1 risk alleles might be present even in individuals who do not self-identify as being of sub-Saharan African descent.

Methods: We non-selectively screened people with kidney failure across Israel for APOL1 risk variants using restriction fragment length polymorphism.

Results: We recruited 1744 individuals from 38 dialysis units in Israel. We identified eight patients of Moroccan Jewish, Bedouin, or Muslim Arab ancestry, who carry at least one G1 or G2 allele. None of the eight patients carried the protective APOL1 p.N264K variant. Furthermore, despite all Bedouin individuals being G2 heterozygous, the G2 minor allele frequency was significantly enriched in kidney failure cases compared to ethnically matched controls (P = .006).

Conclusions: These findings show that APOL1 G1 and G2 allelic variants are present in populations previously not appreciated to possess recent sub-Saharan ancestry and suggest that a single G2 risk variant may confer increased risk for chronic kidney disease in certain population contexts.

Keywords: CKD; chronic renal failure; ethnicity; gene polymorphism; podocytes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no relevant financial interests.

Figures

Graphical Abstract
Graphical Abstract
Figure 1:
Figure 1:
The ethnic and clinical diversity of the Israeli dialysis population. (A) Ethnic identification of 1744 Israeli kidney failure patients. See Methods and Introduction for the named categories of the different ethnic groups. (B) The proportion of cases attributed to common primary kidney diseases within each ethnic group. In both panels, the red dots indicate individuals carrying either APOL1 G1 or G2 alleles. Ethnicity data and primary kidney disease data were not available in 6.99% and 2.92% of the cohort, respectively.

References

    1. Kruzel-Davila E, Wasser WG, Skorecki K. APOL1 nephropathy: a population genetics and evolutionary medicine detective story. Semin Nephrol 2017;37:490–507. 10.1016/j.semnephrol.2017.07.002 - DOI - PubMed
    1. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010;128:345–50. 10.1007/s00439-010-0861-0 - DOI - PMC - PubMed
    1. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010;329:841–5. 10.1126/science.1193032 - DOI - PMC - PubMed
    1. Stevens PE, Ahmed SB, Carrero JJ et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024;105:S117–S314. 10.1016/j.kint.2023.10.018 - DOI - PubMed
    1. Vivante A. Genetics of chronic kidney disease. N Engl J Med 2024;391:627–39. 10.1056/NEJMra2308577 - DOI - PubMed

LinkOut - more resources